Market Value134,732,000
Total Holdings67
File Date2017-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
AGIO / Agios Pharmaceuticals, Inc.
TSRO / TESARO, Inc.
PGEN / Precigen, Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
IOVA / Iovance Biotherapeutics, Inc.
CLVS / Clovis Oncology Inc
SIOX / Sio Gene Therapies Inc.
PCRX / Pacira BioSciences, Inc.
ALDR / Alder BioPharmaceuticals, Inc.
LLY / Eli Lilly and Company Call
CFRX / ContraFect Corp
STML / Stemline Therapeutics, Inc.
SNR / New Senior Investment Group Inc
BIVV / Bioverativ Inc.
PGNX / Progenics Pharmaceuticals, Inc.
0PP / Portola Pharmaceuticals Inc
KITE / Kite Pharma, Inc.
PRTK / Paratek Pharmaceuticals Inc.
MYGN / Myriad Genetics, Inc.
MDCO / Medicines Company
BIB / ProShares Trust - ProShares Ultra Nasdaq Biotechnology
XBI / SPDR Series Trust - SPDR S&P Biotech ETF
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Call
UTHR / United Therapeutics Corporation
SGEN / Seagen Inc
BMY / Bristol-Myers Squibb Company Call
JUNO / Juno Therapeutics, Inc.
MRK / Merck & Co., Inc.
US0153511094 / Alexion Pharmaceuticals, Inc. Call
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
MCRB / Seres Therapeutics, Inc.
SCYX / SCYNEXIS, Inc.
AKBA / Akebia Therapeutics, Inc.
PFE / Pfizer Inc.
AVXS / AveXis, Inc.
HRTX / Heron Therapeutics, Inc.
ADMS / Adamas Pharmaceuticals Inc
ALKS / Alkermes plc
GSK / GSK plc - Depositary Receipt (Common Stock)
GILD / Gilead Sciences, Inc.
GILD / Gilead Sciences, Inc. Call
TECH / Bio-Techne Corporation
CELG / Celgene Corp.
LGND / Ligand Pharmaceuticals Incorporated
REGN / Regeneron Pharmaceuticals, Inc.
BIIB / Biogen Inc.
ACAD / ACADIA Pharmaceuticals Inc.
BMRN / BioMarin Pharmaceutical Inc.
IQV / IQVIA Holdings Inc.
RARE / Ultragenyx Pharmaceutical Inc.
IONS / Ionis Pharmaceuticals, Inc.
NKTR / Nektar Therapeutics
NBIX / Neurocrine Biosciences, Inc.
CRL / Charles River Laboratories International, Inc.
ICPT / Intercept Pharmaceuticals Inc
IBB / iShares Trust - iShares Biotechnology ETF
VRTX / Vertex Pharmaceuticals Incorporated
AMGN / Amgen Inc.
GRFS / Grifols, S.A. - Depositary Receipt (Common Stock)
ILMN / Illumina, Inc.
REPH / Societal CDMO Inc
LABU / Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares
MTD / Mettler-Toledo International Inc.
BMY / Bristol-Myers Squibb Company
ALNY / Alnylam Pharmaceuticals, Inc.
QGEN / Qiagen N.V.
INCY / Incyte Corporation
AXSM / Axsome Therapeutics, Inc.